ライフサイエンスコーパス: allelotype

1 or and normal single nucleotide polymorphism allelotypes.

2 ic recipient tissues all exhibited different allelotypes.

3 vents as a mechanism for generation of these allelotypes.

4 fficient and reliable method of high-density allelotyping.

5 We allelotyped 33 affected individuals from an extensive ME

6 utative tumor suppressor gene was defined by allelotyping 65 cases of sporadic ductal carcinoma in si

7 Our predictions were tested by allelotyping a panel of approximately 30 individuals for

8 lly homogeneous cell subtype populations for allelotype analysis at chromosomes 1p36, 11q23, 14q32, a

9 onic myelocytic leukemia (CML), we performed allelotype analysis in 30 patients with CML as the disea

10 We have previously performed allelotype analysis in CML BC and have detected frequent

11 validated by comparison with microsatellite allelotype analysis of 118 markers in the same tumors.

12 o acute myeloid leukemia (AML), we performed allelotype analysis of 24 individuals using matched MDS

13 This is the first report of an allelotype analysis of esophageal adenocarcinomas.

14 -Mb common region of allelic loss on 8p22 by allelotype analysis.

15 owerful combination of genome-wide molecular allelotyping and CGH has identified recurrent clonal DNA

16 pressor gene (TSG) was previously defined by allelotyping and recently refined by overlapping homozyg

17 was analyzed by Southern and microsatellite allelotyping at 53 different loci on 20 different chromo

18 This comprehensive allelotyping employed flow-sorted cells from diagnostic

19 x resistant and two susceptible strains were allelotyped for 10 genes and 49 random DNA markers to id

20 toid and lung cancer lines was amplified and allelotyped for 33 loci predicted by POMPOUS to be varia

21 We performed high-resolution allelotyping for loss of heterozygosity (LOH) analysis o

22 summary data from >15,000 tumors and primary allelotypes from >4,300 tumors.

23 llite markers was used to initially evaluate allelotypes in TK(+) revertants for patterns associated

24 Detailed examination of allelotypes in TK1- mutants identified two mechanisms fo

25 r heterogeneity of NSCLC into microsatellite allelotyping in a cohort of 48 node-positive stage II pa

26 We used sequenom allelotyping in embryo and adult organs to verify parent

27 a new alternative approach to comprehensive allelotyping in which samples are genotyped for nearly 1

28 Using studies in which primary allelotype information was available, we employed a like

29 Microsatellite allelotyping involved microdissection of the invasive co

30 Additionally, we demonstrate that PCR-based allelotyping is a reliable method for the detection of c

31 We developed a digital RNA allelotyping method for quantitatively interrogating all

32 d out padlock capture, a high-resolution RNA allelotyping method, to study X chromosome inactivation

33 gosity (LOH), we generated a high-resolution allelotype of 35 ductal carcinoma in situ cases and comp

34 We present the comprehensive allelotype of 82 xenografted pancreatic or biliary cance

35 These data represent the first comprehensive allelotype of esophageal adenocarcinoma and show the fea

36 Studies of the allelotype of human cancers have provided valuable insig

37 mors, we performed a detailed microsatellite allelotype of lesions thought to arise from the renal co

38 Genome-wide allelotyping of early passage N-ethyl-N-nitrosourea-expo

39 gap7) to 20 cM on mouse chromosome 8 and for allelotyping of mouse liver tumor DNAs.

40 Allelotyping of pooled genomic DNA is a common approach

41 the model tumor suppressor RB1, we performed allelotyping of single-nucleotide polymorphic sites and

42 In this report, we describe the sequence allelotyping of the Ha-ras variable number tandem repeat

43 tional profile for each patient based on the allelotyping of the primary tumor and lymph node deposit

44 Extensive allelotyping of this class of variation has not been pos

45 Global patterns of LOH can be discerned by allelotyping of tumors with polymorphic genetic markers.

46 al patterns of LOH can be understood through allelotyping of tumors with polymorphic genetic markers.

47 DNA pools for cases and controls were allelotyped on the Affymetrix 500K GeneChip for each cen

48 velopment, we performed microsatellite-based allelotypes on primary mammary adenocarcinomas and lung

49 more stringent approach in computing robust allelotypes resulting in 94.4% of the 1095 informative r

50 CGH results agreed with allelotyping results at 92% of the informative loci stud

51 Numerous cytogenetic and allelotype studies have reported frequent loss of hetero

52 Numerous allelotype studies indicate that allelic deletions Inclu

53 Allelotyping studies have been extensively used in a wid

54 t reported in Wilms' tumourigenesis and that allelotyping studies may fail to identify regions contai

55 Previous allelotyping studies of epithelial ovarian carcinoma sug

56 Allelotyping studies suggest that allelic losses at one

57 A recent allelotyping study by our group identified frequent alle

58 A genome-wide allelotyping study of 28 human PETs was undertaken to id

59 HCC mutational allelotyping targeted 10 genomic loci (1p, 3p, 5q, 7q, 8

60 up of 41 subjects whose primary tumours were allelotyped, the fractional allelic loss (FAL) at 39 aut

61 When we applied allelotyping to two pairs of sibling human embryonic ste

62 the four subclasses were microdissected and allelotyped using genome-wide single nucleotide polymorp

63 Genome-wide allelotype was performed using 169 fluorescently labeled

64 Allelotyping was done for bronchial epithelial cells and

65 Semi automated fluorescein based allelotyping was performed to identify loss of heterozyg

66 The high-confidence allelotypes were analyzed to obtain an estimate of the m

67 ybridization (CGH) and genome-wide molecular allelotyping were performed with a large group of uremia

68 ent allelic imbalance (AI) and correlate the allelotype with clinical features of disease.

69 We have used genome-wide allelotyping with 348 polymorphic autosomal markers spac

70 d with aggressive growth by performing Chr 1 allelotyping with microsatellite markers in microdissect

71 possibility of individual tumor genome-wide allelotyping with potential prognostic and diagnostic ap